Silence Therapeutics (SLN) Tax Rate (2024 - 2025)
Silence Therapeutics' (SLN) quarterly Tax Rate came in at 0.0% in Q3 2025, up 13.0% year-on-year from 0.0% in Q3 2024, and up 86.95% quarter-over-quarter from 0.04% in Q2 2025.
Silence Therapeutics (SLN) Tax Rate (2024 - 2025) Analysis & Trends
Silence Therapeutics has disclosed Tax Rate across 2 years of filings, most recently posting 0.0% for Q3 2025.
- Tax Rate for Q3 2025 came in at 0.0%, up 13.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 83.0% YoY), and the FY2025 annual result was 0.01%, up 189.0% from the prior year.
- Tax Rate came in at 0.0% for Q3 2025 at Silence Therapeutics, up from 0.04% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 2.57% in Q4 2024 to a low of 11.8% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.04% |
| Dec 31, 2024 | 2.57% |
| Dec 31, 2024 | 2.57% |
| Sep 30, 2024 | -0.14% |
| Sep 30, 2024 | -0.14% |
| Jun 30, 2024 | -1.17% |
| Jun 30, 2024 | -1.17% |
| Mar 31, 2024 | -11.80% |
| Mar 31, 2024 | -11.80% |